Skip to content

Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous

Role of Oral Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous in Chronic Kidney Disease

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04311645
Enrollment
90
Registered
2020-03-17
Start date
2020-08-01
Completion date
2021-08-31
Last updated
2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease stage3

Brief summary

The study aims to explore the ability of Oral activated charcoal to adsorb uremic toxins limiting the progression of chronic kidney disease and delaying the need for hemodialysis in patients with CKD stages III and IV. To compare its effect with the effect of dry seeds as absorbents of uremic toxins

Detailed description

In recent years, chronic kidney disease(CKD) has become a worldwide public health issue. The main factors affecting the prognosis of patients with chronic kidney disease are its complications, including cardiovascular and cerebrovascular diseases, malnutrition, inflammation, atherosclerosis syndrome, and anemia. The accumulation of uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, is implicated in the progression of renal failure and cardiovascular disease. For many patients, chronic kidney disease (CKD) is a progressive condition marked by deteriorating renal function ultimately leading to end-stage renal disease (ESRD) and many patients refuse to start chronic hemodialysis. Therapeutic approaches that decrease the level of uremic toxins are a rational method for inhibiting this progression. Many researches have been done aiming to find alternatives for chronic hemodialysis either for economic issues or psychological issues especially in elderly patients, as example: * Gum Arabic in the remedy and amelioration of kidney dysfunction and end-stage renal disease * skin as excretory root for urea, increasing sweat from sweat glands can support kidney function by excreting a good amount of what kidneys naturally excrete. * The oral charcoal adsorbent reduces serum levels of indoxyl sulfate through adsorption of indole converted from dietary tryptophan in the gastrointestinal tract decreasing serum creatinine and urea level . In this study, the clinical data supporting the role of oral activated charcoal in a dose of 30gm/ day for slowing the progression of CKD will be reviewed. In this study, a trial will be done using dry seeds (lentils as an example) as an absorbent for uremic toxins comparing its effect with the effect of oral activated charcoal.

Interventions

Activated charcoal

DIETARY_SUPPLEMENTDry seeds

Dry seeds

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Patients with CKD stages iii and iv Patients with age more than 18 years old

Exclusion criteria

Patients on regular hemodialysis Patients with age less than 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Mean of blood urea, creatinine and phosphorous in patients with CKD before and after oral activated charcoalbaselineto asses the mean of blood urea, creatinine and phosphorous in CKD patient before and after administration of activated charcoal

Secondary

MeasureTime frameDescription
comparison of dry seeds and activated charcoal in limitting progression of chronic kidney diseasebaselineTo compare dry seeds with activated charcoal as as alternative natural cheap methods that may help in limitting progression of CKD by measuring blood urea, creatinine, and phosphorous in all 3 groups of the study

Contacts

Primary Contactfarrag s mohamed
faragsayed99@gmail.com01143681697
Backup ContactAshraf A Al-Shazly, Prof

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026